Hosseininasab Masumeh, Jahangard-Rafsanjani Zahra, Mohagheghi Abbas, Sarayani Amir, Rashidian Arash, Javadi Mohammadreza, Ahmadvand Alireza, Hadjibabaie Molouk, Gholami Kheirollah
Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;
Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran;
Am J Hypertens. 2014 Nov;27(11):1339-45. doi: 10.1093/ajh/hpu062. Epub 2014 Apr 26.
Self-monitoring is reported to have limited efficacy for hypertension management in high-income countries. In this study, we aimed to evaluate the effect of self-monitoring on blood pressure (BP) control in an Iranian population.
A randomized controlled trial was conducted on 196 mild to moderate hypertensive patients in an outpatient cardiovascular clinic. Patients in the intervention group received a wrist self-monitoring device and were educated to measure and document their BP daily during the study period (24 weeks). Patients in the control group received usual care. Three follow-up visits with the physician were scheduled for all patients (weeks 4, 12, and 24), and the investigator assessed adherence to medications after each visit (pill counting). The primary outcome (BP) was compared between groups using repeated-measure analysis of variance.
One hundred ninety patients completed the study. Systolic BP (144.4±7.4 vs 145.9±6.4mm Hg) and diastolic BP (85.5±6.9 vs. 85.1±7.7mm Hg) were similar between groups at baseline. The trend of BP was not significantly different between groups during the study period. Systolic and diastolic BP decreased significantly in both groups at the first follow-up visit (systolic BP: 132.6 vs. 133.4mm Hg; diastolic BP: 77.4 vs. 77.2mm Hg). In the intervention group, we observed a small continued decrease in diastolic BP up to week 24 BP (P = 0.01). Both groups showed adherence rates >95% during the study period.
Our study could not confirm that self-monitoring can improve BP control in patients with frequent medical visits.
据报道,在高收入国家,自我监测对高血压管理的效果有限。在本研究中,我们旨在评估自我监测对伊朗人群血压控制的影响。
在一家门诊心血管诊所对196例轻度至中度高血压患者进行了一项随机对照试验。干预组患者获得了一个腕式自我监测设备,并接受教育,在研究期间(24周)每天测量并记录血压。对照组患者接受常规护理。所有患者安排了三次与医生的随访就诊(第4、12和24周),每次就诊后研究者评估药物依从性(计数药片)。使用重复测量方差分析比较组间的主要结局(血压)。
190例患者完成了研究。两组在基线时收缩压(144.4±7.4 vs 145.9±6.4mmHg)和舒张压(85.5±6.9 vs 85.1±7.7mmHg)相似。在研究期间,两组间血压趋势无显著差异。在第一次随访就诊时,两组收缩压和舒张压均显著下降(收缩压:132.6 vs 133.4mmHg;舒张压:77.4 vs 77.2mmHg)。在干预组中,我们观察到直至第24周舒张压持续有小幅下降(P = 0.01)。在研究期间,两组的依从率均>95%。
我们的研究无法证实自我监测能改善频繁就诊患者的血压控制。